Table 1 Characteristics of the study cohort exposed to the PAF and unexposed matched controls. May 2015–April 2016
total – n (%) | PAF exposed group | Matched unexposed controls | p value |
|---|---|---|---|
348 (100) | 827 (100) | ||
age group | |||
< 35 | 12 (3.4) | 26 (3.1) | 0.961 |
35–55 | 29 (8.3) | 68 (8.2) | |
55–65 | 37 (10.6) | 81 (9.8) | |
> = 65 | 270 (77.6) | 652 (78.8) | |
Gender | |||
Female | 190 (54.6) | 431 (52.1) | 0.437 |
Male | 158 (45.4) | 396 (47.9) | |
Infectious Diagnosis | |||
Primary diagnosis | |||
Primary diagnosis of pneumonia and secondary diagnosis of UTI | 4 (1.1) | 6 (0.7) | 0.012 |
Primary diagnosis of pneumonia | 26 (7.5) | 72 (8.7) | |
Primary diagnosis of UTI | 37 (10.6) | 45 (5.4) | |
Lack of primary diagnosis of infection | 281 (80.7) | 704 (85.1) | |
Secondary diagnosis | |||
Secondary diagnosis of pneumonia and UTI | 9 (2.6) | 22 (2.7) | 0.903 |
Secondary diagnosis of pneumonia | 48 (13.8) | 127 (15.4) | |
Secondary diagnosis of UTI | 79 (22.7) | 178 (21.5) | |
Lack of secondary diagnosis of infection | 212 (60.9) | 500 (60.5) | |
Charlson Comorbidity Score | |||
0 | 252 (72.4) | 507 (61.3) | 0.001 |
1 or 2 | 75 (21.6) | 230 (27.8) | |
> 3 | 21 (6) | 90 (10.9) | |